BENFANTE, Alida
 Distribuzione geografica
Continente #
NA - Nord America 5.760
AS - Asia 2.339
EU - Europa 2.272
SA - Sud America 385
AF - Africa 73
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.837
Nazione #
US - Stati Uniti d'America 5.681
SG - Singapore 869
RU - Federazione Russa 854
CN - Cina 585
IT - Italia 431
BR - Brasile 307
VN - Vietnam 223
HK - Hong Kong 212
FI - Finlandia 187
PL - Polonia 157
DE - Germania 142
GB - Regno Unito 115
FR - Francia 94
JP - Giappone 83
BD - Bangladesh 82
UA - Ucraina 74
IE - Irlanda 70
KR - Corea 58
IN - India 54
CA - Canada 43
NL - Olanda 32
IQ - Iraq 24
MX - Messico 24
TR - Turchia 23
ZA - Sudafrica 22
ID - Indonesia 19
PK - Pakistan 19
SE - Svezia 19
AR - Argentina 18
ES - Italia 17
AT - Austria 13
VE - Venezuela 13
CI - Costa d'Avorio 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
MA - Marocco 11
SA - Arabia Saudita 11
BE - Belgio 10
CH - Svizzera 10
CL - Cile 10
MY - Malesia 9
CZ - Repubblica Ceca 8
KE - Kenya 7
PY - Paraguay 7
UZ - Uzbekistan 7
AU - Australia 6
GR - Grecia 6
IR - Iran 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
EC - Ecuador 5
ET - Etiopia 5
JO - Giordania 5
BO - Bolivia 4
CR - Costa Rica 4
LB - Libano 4
PE - Perù 4
PH - Filippine 4
TN - Tunisia 4
EG - Egitto 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
PT - Portogallo 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
JM - Giamaica 2
KG - Kirghizistan 2
MM - Myanmar 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
RS - Serbia 1
Totale 10.836
Città #
Ashburn 743
Fairfield 736
Singapore 570
Woodbridge 335
Chandler 316
Seattle 288
Cambridge 283
Houston 273
Wilmington 272
San Jose 269
Hong Kong 209
Zgierz 141
Moscow 140
Des Moines 133
Council Bluffs 114
Ann Arbor 112
Beijing 104
Medford 90
Helsinki 87
Los Angeles 85
New York 83
Tokyo 81
Dallas 78
Ho Chi Minh City 74
Santa Clara 73
Hanoi 70
Dublin 69
Palermo 64
Altamura 63
Lauterbourg 59
Princeton 56
Nanjing 53
Lawrence 49
The Dalles 46
Buffalo 43
San Diego 43
Hefei 40
Chicago 39
Frankfurt am Main 36
London 33
Dearborn 32
Jacksonville 32
Milan 29
São Paulo 28
Seoul 26
Orem 25
Rome 23
Jinan 22
Shenyang 21
Boardman 20
Ludwigshafen am Rhein 19
Tianjin 18
Nuremberg 17
Atlanta 15
Changsha 15
Falls Church 15
Kilburn 15
Phoenix 15
Amsterdam 14
Montreal 14
San Paolo di Civitate 14
Chennai 13
Tulsa 13
Abidjan 12
Johannesburg 12
Lappeenranta 12
Naples 12
Zhengzhou 12
Haiphong 11
Hebei 11
Nanchang 11
Brussels 10
Columbus 10
Denver 10
Salt Lake City 10
Warsaw 10
Jiaxing 9
Lahore 9
Manchester 9
Mexico City 9
Rio de Janeiro 9
Stockholm 9
Vancouver 9
Baghdad 8
Boston 8
Guangzhou 8
Harbin 8
Norwalk 8
Paris 8
Pune 8
Saint Petersburg 8
Shanghai 8
Tappahannock 8
Brasília 7
Brooklyn 7
Campo Grande 7
Hangzhou 7
Ningbo 7
Redwood City 7
Riyadh 7
Totale 7.242
Nome #
Airway distensibility by HRCT in asthmatics and COPD with comparable airway obstruction 283
Arterial stiffness in symptomatic smokers with normal lung function 272
Asthmatics with high levels of serum surfactant protein D have more severe disease 265
Prevalence of arterial hypertension and characteristics of nocturnal blood pressure profile of asthma patients according to therapy and severity of the disease: The bada study 253
Asthma in the elderly: A different disease? 250
Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects 250
Challenges in the pharmacological treatment of geriatric asthma 241
Early Lung Function Abnormalities in Acromegaly. 228
Serum low density lipoprotein subclasses in asthma 220
How Effective and Safe Is Bronchial Thermoplasty in "real Life" Asthmatics Compared to Those Enrolled in Randomized Clinical Trials? 213
Exhaled nitric oxide is associated with cyclic changes in sexual hormones 211
Asthma in the older adult: Presentation, considerations and clinical management 211
Validation of lung densitometry threshold at CT for the distinction between senile lung and emphysema in elderly subjects. 198
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics 198
Airway Wall Thickness By HRCT Does Not Affect Airway Distensibility In Asthma And COPD 197
Are biological drugs effective and safe in older severe asthmatics? 196
Does the frequency of switching inhalers represent a predictive factor of exacerbation in asthma? 194
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients 191
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD 191
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 183
Lung penetration and patient adherence considerations in the management of asthma: Role of extra-fine formulations 182
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD 177
Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects 176
Management of suspected COVID-19 patients in a low prevalence region 176
Urinary Incontinence in Chronic Obstructive Pulmonary Disease: A Common Co-morbidity or a Typical Adverse Effect? 174
Densitometria TC nella diagnosi radiologica differenziale tra polmone senile ed enfisema nell’ anziano 173
Serum Surfactant Protein D as a Marker of Asthma Severity 173
CT densitometry-based differential diagnosis between emphysematous and non-emphysematous lungs in elderly patients. 172
The Arg/Arg polymorphism of the ADRB2 is associated with the severity of allergic asthma 166
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 166
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 165
Sleep Disturbances in COPD are Associated with Heterogeneity of Airway Obstruction 163
A 79-year-old-man with SARS-CoV-2 pneumonia and unusual pulmonary co-infection 154
Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients 153
Pharmacological Management of Elderly Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation? 152
The geriatric asthma: pitfalls and challenges 152
Distribution and lower limit of normal of computed tomography (CT) density in non emphysematous senile lungs 148
Serum lipoproteins are not associated with the severity of asthma 143
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 140
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 139
The anti-inflammatory properties of tiotropium 137
A novel approach to investigate severe asthma and COPD: the 3d ex vivo respiratory mucosa model 134
How to unveil chronic respiratory diseases in clinical practice? A model of alliance between general practitioners and pulmonologists 134
Patients with bronchiectasis have a lower combined risk of cardiovascular risk factors and cardiovascular comorbidity compared to patients with COPD 130
Fever and dyspnoea in a tracheostomised patient 130
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience 129
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians 127
Comparison between Suspected and Confirmed COVID-19 Respiratory Patients: What Is beyond the PCR Test 125
The asthma-COPD overlap syndrome (ACOS): hype or reality? That is, a curiosity for the media or an opportunity for physicians? 124
Echocardiographic Evaluation of the Cardiac Chambers in Asthmatic Patients: The BADA (Blood Pressure Levels, Clinical Features and Markers of Subclinical Cardiovascular Damage of Asthma Patients) Study-ECO 122
Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study 118
Impact of Actively Offering Influenza Vaccination to Frail People during Hospitalisation: A Pilot Study in Italy 116
Transient asymptomatic bradycardia and Remdesivir in COVID-19 patients 113
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 110
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave 110
Predictive Biomarkers of Acute Kidney Injury in COVID-19: Distinct Inflammatory Pathways in Patients with and Without Pre-Existing Chronic Kidney Disease 109
Valori di densità TC nella diagnosi differenziale tra polmone senile ed enfisema 108
The potential role of SP-D as an early biomarker of severity of asthma 108
Valutazione della risposta bronchiale ai respiri profondi mediante HRCT nell’asma e nella BPCO 107
HRCT evaluation of bronchial response to deep inspiration in asthma and chronic obstructive pulmonary disease (COPD) 106
Are nighttime respiratory symptoms assessed by asthma control test affected by comorbidities? 100
Severe asthma and COVID-19: lessons from the first wave 97
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 97
Prioritizing care for severe asthma during SARS-CoV-2 pandemic 90
Severe asthma at COVID-19 time: What is new on biologic therapies 89
Serum surfactant protein D and exhaled nitric oxide as biomarkers of early lung damage in systemic sclerosis 82
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 78
The prevalence of sleep impairments and predictors of sleep quality among patients with asthma 68
The multidisciplinary team reduces the time to idiopathic pulmonary fibrosis diagnosis in a real-life setting 67
Ex vivo air–liquid interface respiratory mucosa platform to study type 2–driven asthma 64
Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model 55
Current status of biological therapy use for older adults with severe asthma 52
The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study 46
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 44
Ascending aortic thrombosis in COVID respiratory patient: the “perfect storm” 38
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 33
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study 30
From asthma theory to practice: insights from real life 28
Coronavirus disease 2019 and severe asthma 27
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 27
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts 25
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 19
null 3
null 3
Totale 11.348
Categoria #
all - tutte 39.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 57 85
2021/2022696 53 94 35 18 16 33 29 32 103 133 43 107
2022/20231.020 77 194 21 98 105 137 142 69 116 7 40 14
2023/2024449 15 81 19 44 57 80 53 27 6 10 7 50
2024/20251.238 29 85 144 73 43 42 89 72 85 125 172 279
2025/20264.621 323 145 248 364 497 662 683 611 419 390 279 0
Totale 11.348